BC Innovations | Oct 18, 2018
Distillery Therapeutics

Cardiovascular

INDICATION: Cardiovascular Rat and mouse studies suggest inhibiting the long non-coding RNA (lncRNA) NEAT1 could help treat neointimal hyperplasia. In carotid artery samples from a rat model of angioplasty-associated neointimal hyperplasia, NEAT1 levels were higher...
BC Innovations | May 2, 2018
Distillery Techniques

Biomarkers

TECHNOLOGY: Gene profiling Tumor mutations of 22 genes could help diagnose prostate cancer, and mutations in two of them could help predict patient outcomes. Whole-genome sequencing of 112 primary and metastatic prostate cancer and matched...
BC Innovations | Aug 4, 2016
Distillery Therapeutics

Therapeutics: Nuclear paraspeckle assembly transcript 1 (NEAT1)

Cancer INDICATION: Breast cancer; skin cancer; cancer Patient sample, cell culture and mouse studies suggest inhibiting NEAT1 could help treat breast cancer, squamous cell carcinoma (SCC) of the skin and other cancers. In a human...
BC Innovations | Feb 19, 2015
Distillery Therapeutics

Therapeutics: Estrogen receptor α; nuclear paraspeckle assembly transcript 1 (NEAT1)

Cancer INDICATION: Prostate cancer Studies in mice and human samples suggest inhibiting NEAT1 could help treat estrogen receptor α-positive prostate cancer. In tumor samples from patients with prostate cancer, high NEAT1 expression was associated with...
Items per page:
1 - 4 of 4